We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+6.11%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.82B
AUM Growth
-$26.9M
Cap. Flow
-$65.9M
Cap. Flow %
-3.62%
Top 10 Hldgs %
25.49%
Holding
265
New
15
Increased
38
Reduced
176
Closed
16

Top Buys

Rank Stock Value
1
FOUR icon
Shift4
FOUR
+$20.4M
2
LKQ icon
LKQ Corp
LKQ
+$13.6M
3
PRLB icon
Protolabs
PRLB
+$5.49M
4
GNTX icon
Gentex
GNTX
+$5.07M
5
PRMB
Primo Brands
PRMB
+$4.23M

Top Sells

Rank Stock Value
1
LRN icon
Stride
LRN
+$15.4M
2
YOU icon
Clear Secure
YOU
+$9.41M
3
SITM icon
SiTime
SITM
+$7.56M
4
MGPI icon
MGP Ingredients
MGPI
+$6.55M
5
DOCS icon
Doximity
DOCS
+$6.52M

Sector Composition

Rank Sector Weight
1 Healthcare 30.8%
2 Technology 27.79%
3 Industrials 15.85%
4 Communication Services 7.19%
5 Consumer Discretionary 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRN icon
1
Stride
LRN
$3.48B
$69.6M 3.82%
669,440
-162,410
-20% -$15.4M
DFIN icon
2
Donnelley Financial Solutions
DFIN
$1.21B
$52.9M 2.91%
843,758
-55,809
-6% -$3.48M
TKO icon
3
TKO Group
TKO
$13.5B
$51.8M 2.85%
364,598
-23,894
-6% -$3.12M
ACIW icon
4
ACI Worldwide
ACIW
$5.81B
$49.3M 2.71%
950,577
-121,417
-11% -$6.46M
ARLO icon
5
Arlo Technologies
ARLO
$1.59B
$45.6M 2.5%
4,070,874
+1,398
+0% +$16.3K
VRNA
6
DELISTED
Verona Pharma
VRNA
$44.3M 2.43%
954,616
-30,460
-3% -$1.14M
PBH icon
7
Prestige Consumer Healthcare
PBH
$2.35B
$43M 2.36%
550,812
-22,722
-4% -$1.76M
WNS
8
DELISTED
WNS Holdings
WNS
$37.4M 2.05%
789,140
-40,096
-5% -$1.98M
ESTA icon
9
Establishment Labs
ESTA
$2.72B
$35.5M 1.95%
770,667
-22,633
-3% -$987K
MEDP icon
10
Medpace
MEDP
$16B
$34.7M 1.91%
104,483
-5,314
-5% -$1.8M
EEFT icon
11
Euronet Worldwide
EEFT
$2.77B
$33.5M 1.84%
325,402
-16,921
-5% -$1.72M
AGM icon
12
Federal Agricultural Mortgage
AGM
$2.38B
$33.1M 1.82%
168,009
-4,120
-2% -$817K
LGND icon
13
Ligand Pharmaceuticals
LGND
$5.84B
$32.7M 1.79%
304,925
-7,954
-3% -$899K
XPO icon
14
XPO
XPO
$23.6B
$32.6M 1.79%
248,922
-13,617
-5% -$1.84M
YOU icon
15
Clear Secure
YOU
$5.49B
$28.3M 1.56%
1,063,169
-311,501
-23% -$9.41M
AWI icon
16
Armstrong World Industries
AWI
$7.31B
$27.8M 1.53%
196,723
-10,227
-5% -$1.5M
FN icon
17
Fabrinet
FN
$15.8B
$27.5M 1.51%
124,988
-5,617
-4% -$1.35M
ZD icon
18
Ziff Davis
ZD
$1.92B
$26.8M 1.47%
493,472
-7,841
-2% -$411K
WEX icon
19
WEX
WEX
$6.3B
$25.3M 1.39%
144,030
-10,003
-6% -$1.88M
DOCS icon
20
Doximity
DOCS
$3.75B
$25M 1.37%
467,660
-133,151
-22% -$6.52M
FOUR icon
21
Shift4
FOUR
$4.15B
$24M 1.32%
231,034
+205,361
+800% +$20.4M
ASND icon
22
Ascendis Pharma A/S
ASND
$16.1B
$22.6M 1.24%
163,888
+3,274
+2% +$430K
LMAT icon
23
LeMaitre Vascular
LMAT
$2.29B
$21.7M 1.19%
235,076
-26,230
-10% -$2.52M
TRAK icon
24
ReposiTrak
TRAK
$153M
$20.5M 1.13%
927,312
-86,970
-9% -$1.84M
FC icon
25
Franklin Covey
FC
$236M
$20.1M 1.1%
533,924
-15,221
-3% -$585K
1
2 3 4 5

Similar funds

GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
JCM
Jacobi Capital Management Pittston, Pennsylvania $1.79B AUM 17.94% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return

Rice Hall James & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, Rice Hall James & Associates held 265 positions worth $1.82B, down 1.5% from $1.85B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $65.9M in Q4 2024, closing 16 positions and reducing 176 holdings. Its most notable exit was SiTime, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Protolabs worth $5.97M.

  • Rice Hall James & Associates's largest Q4 2024 buy was Protolabs: 152,783 shares worth $5.97M.
  • Rice Hall James & Associates added most to Shift4 in Q4 2024, an estimated $20.4M increase.
  • Rice Hall James & Associates's biggest Q4 2024 reduction was Stride, cutting an estimated $15.4M.
  • Rice Hall James & Associates fully exited SiTime in Q4 2024, selling an estimated $7.56M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $1.82B portfolio in Q4 2024.
  • Rice Hall James & Associates opened 15 new positions and closed 16 in Q4 2024.
  • Rice Hall James & Associates's portfolio value fell 1.5% quarter-over-quarter to $1.82B.

Based on Rice Hall James & Associates's 13F filing for Q4 2024, filed 31 Jan 2025.